Loading organizations...
Key people at Onco360.
Onco360 operates as an oncology specialty pharmacy, providing comprehensive pharmaceutical care solely for cancer patients. It offers specialized clinical support from Board-Certified Oncology Pharmacists and nurses for meticulous management. Services include access to limited distribution oncology medications, financial assistance, insurance verification, and clinical counseling, supporting patients throughout their journey.
The company was established in 2003, beginning as a single-location pharmacy in Louisville, Kentucky. It was founded on the insight that cancer patients require a uniquely focused and specialized pharmaceutical care model, distinct from general specialty pharmacies. This principle guided its development into a dedicated nationwide oncology network.
Onco360 serves cancer patients, physicians, pharmaceutical partners, payers, and hospitals. Its vision enhances patient lives by navigating care intricacies through advanced oncology clinical expertise. The company ensures timely and affordable medication access and delivers compassionate, patient-centric support.
Key people at Onco360.
Onco360 has 1 tracked investment across 1 company. The latest tracked deal is $18.0M Series A in RxLightning in June 2023.
| Date | Company | Round | Lead Investor(s) | Co-Investor(s) |
|---|---|---|---|---|
| Jun 1, 2023 | RxLightning | $18.0M Series A | Josh Flum | HealthX Ventures, Vensana Capital, Hearst Ventures, Carrie (Hurwitz) Williams, Novartis, Rana Lonnen |